Cancer MDT Pathway Coordinator (Band $1) - Airedale NHS Foundation Trust

Be part of our future landscape At Airedale, we are committed to promoting equality, diversity and inclusion. We actively encourage applications irrespective of people’s age, lived experience of living with a disability or long-term conditions, gender, race or ethnicity, religion or belief, sexual orientation, or other personal circumstances. Increasing our diversity and supporting our organisation to be more inclusive is a key priority here at Airedale and our teams are at the centre of how we work towards this. We appreciate all people may have diverse and individual needs and we pride ourselves on supporting all people to thrive and flourish at work. We have frameworks in place that support reasonable adjustments and flexible working for colleagues throughout their working lives which starts at recruitment. These are exciting times for Airedale. We have the once-in-a-career opportunity to be involved in the planning and building of a completely new hospital here on our Steeton site by 2030. By joining us now you’ll be a key part of our journey over the next few years, with the chance to input into a state-of-the-art, modern healthcare facility that will deliver care to our communities for decades to come. We are also on the journey to a new electronic patient record, part of our wider ambition for our digital future – a future that builds on our significant telemedicine and digital care success. Ultimately, what makes Airedale special is our people. Not just our staff, but our volunteers, patients, visitors, and wider population who make up the Airedale family. This is a Trust that sits at the heart of our community, and our communities are very proud of their Trust. Please read the attached AI statement prior to submitting any application Job overview We are seeking two enthusiastic and highly motivated individuals with the appropriate NHS experience to join our Cancer Lead Team. The main functions of the team are to organise and facilitate cancer MDT meetings a...